Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Humacyte
MedTech
Humacyte's regenerative tissues ace vascular trauma trial
Humacyte unveiled results showing that its Human Acellular Vessels could outperform synthetic grafts in patency, amputation and infection rates.
Andrea Park
Sep 12, 2023 10:53am
Insulet tapped to replace SVB on S&P 500
Mar 13, 2023 3:20pm
Biogen taps new board chair—Chutes & Ladders
Mar 10, 2023 9:30am
Fierce Biotech launches layoff tracker—Chutes and Ladders
Apr 8, 2022 9:30am
Humacyte takes the SPAC track to Wall Street
Feb 17, 2021 8:20am
Fresenius inks $150M deal for Humacyte’s blood vessel implant
Jun 11, 2018 8:00am
